Cargando…
p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA‐320a in lung cancer
BACKGROUND: Lung cancer is among the most frequently diagnosed types of cancer worldwide, with high morbidity and mortality. Metastasis accounts for the deadliest and most poorly understood feature of lung cancer. Herein, we demonstrate that SND1 (also known as p100) acts as a candidate metastasis a...
Autores principales: | Xing, Aimin, Pan, Li, Gao, Jingzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754290/ https://www.ncbi.nlm.nih.gov/pubmed/29159900 http://dx.doi.org/10.1111/1759-7714.12564 |
Ejemplares similares
-
Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer
por: OKATO, ATSUSHI, et al.
Publicado: (2016) -
MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin
por: Yu, Juan, et al.
Publicado: (2016) -
Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma
por: Fang, Zanxi, et al.
Publicado: (2015) -
MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation
por: Li, Yong-Shuang, et al.
Publicado: (2019) -
MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis
por: Lu, Xiaomei, et al.
Publicado: (2022)